David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder

David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

SKU: pb-40-3-sheehan Categories: Psychopharmacology Bulletin, VOL 40 No. 3 Articles Tags: aminobutyric-acid-gaba, anxiety, b-ashok-raj, david-v-sheehan, juris-janavs, kathy-harnett-sheehan, mba, md, panic-disorder, phd, selective-gaba-reuptake-inhibitor, tiagabine

Description

Description

David V. Sheehan, MD Link

NEGATIVE AND FAILED CLINICAL TRIAL REPORTS

An Open-Label Study of Tiagabine in Panic Disorder

David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, B. Ashok Raj, MD, and Juris Janavs, MD